Is non-chlamydial non-gonococcal urethritis associated with significant clinical complications in men? A systematic review by Fairhead, Cassandra E.L. et al.
Curr Urol 2020;14:1–13
DOI: 10.1159/000499266
Key Words
Abstract
Fax +41 61 306 12 34
E-Mail karger@karger.com
www.karger.com
© 2020 The Author(s)
Published by S. Karger AG, Basel
This article is licensed under the Creative Commons Attribution- 
NonCommercial-NoDerivatives 4.0 International License (CC BY- 
NC-ND) (http://www.karger.com/Services/OpenAccessLicense). 
Usage and distribution for commercial purposes as well as any dis-
tribution of modified material requires written permission.
Urethritis • Balanoposthitis • Epididymitis • Complication • 
Reactive arthritis
Background: It is estimated that between 50 and 89% of 
non-gonococcal urethritis is not caused by Chlamydia tra-
chomatis. Associations between non-chlamydial non-gono-
coccal urethritis (NCNGU) with balanoposthitis, epididy-
mo-orchitis and reactive arthritis have been suggested, but 
evidence to support these often-theoretical relationships is 
sparse and further investigation is called for. Concerns over 
increasing antimicrobial resistance has rendered the need 
for clarity over this question ever more pressing in recent 
years. A review of the current evidence on the complications 
of NCNGU in men is therefore urgently warranted. Objec-
tive: This systematic review summarizes and evaluates the 
available evidence that NCNGU, whether symptomatic or 
asymptomatic, causes the significant complications that are 
already well-recognized to be associated with non-gonococ-
cal urethritis. These significant complications are epididy-
mo-orchitis, balanoposthitis, and sexually-acquired reactive 
arthritis (Reiter’s syndrome) including arthritis or conjunc-
tivitis. Summary: We conducted a systematic review and 
qualitative synthesis using the Preferred Reporting Items 
for Systematic Reviews and Meta-Analysis framework. Five 
databases (PubMed, EMBASE, Cumulative Index to Nursing 
and Allied Health Literature, PsycINFO, and British Nursing 
Index) were searched. We included studies that measured 
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Introduction
It is estimated that between 50 and 89% of non-gono-
coccal urethritis is not caused by Chlamydia trachomatis 
[1]. Since its isolation in 1980, Mycoplasma genitalium 
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clinical outcome after diagnosis of NCNGU in men. Bias was 
assessed using variations of the Newcastle-Ottawa scale. 
Data were extracted and entered into a pre-written data 
abstraction proforma. Seven peer-review studies were in-
cluded. This included 2 retrospective cohort studies, 1 case 
series, 2 case reports and 2 cross-sectional studies. The 
studies described and analyzed 3 types of complication: 
balanitis, posthitis and/or meatitis; reactive arthritis and/or 
conjunctivitis; and epididymitis. All studies reported one or 
more complications. Key Messages: This review identifies an 
important avenue for future research: while the available ev-
idence suggests that NCNGU has the potential to cause sig-
nificant complications in men, with the strongest evidence 
existing for balanitis, posthitis and/or meatitis, the nature 
and significance of these relationships is far from clear. The 
findings of this review suggest that prospective, adequately 
powered research into whether there is a causal link be-
tween NCNGU and significant clinical complications in men 
would be highly worthwhile. The findings of this review raise 
important questions about the utility of the term NCNGU in 
research and clinical practice.
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has been increasing recognized as an important cause of 
non-chlamydial non-gonococcal urethritis (NCNGU) in 
men. Associations with balanoposthitis, epididymo-or-
chitis and reactive arthritis have been suggested, but ev-
idence to support these often theoretical relationships is 
sparse and further investigation called for, particularly 
given concerns that patients positive for Mycoplasma 
genitalium report histories of lower genital tract pain, 
epididymitis and arthritis [2–6]. The need for clarity over 
the question of the complications of Mycoplasma gen-
italium and NCNGU in general has become even more 
pressing in recent years. Macrolide resistance in Myco-
plasma genitalium has reached such a high prevalence 
that the British Association for Sexual Health and HIV 
(BASHH) has warned that within a decade the pathogen 
has the capacity to become a ‘superbug’ [6, 7].
In women Mycoplasma genitalium infection can 
cause serious complications such as pelvic inflammatory 
disease, and BASHH estimates that of the 3,000 cases 
of Mycoplasma genitalium-related pelvic inflammatory 
disease that occur each year in the UK approximately 90 
women become infertile [8]. While screening of asymp-
tomatic men for Mycoplasma genitalium has been shown 
not to be cost effective, it is speculated that testing for 
the pathogen in cases of symptomatic male urethritis 
would lead to both improved clinical outcomes and bet-
ter antimicrobial stewardship [9]. In order to evidence 
this claim, particularly in a climate where increasing fi-
nancial pressure on sexual health services leaves public 
health commissioners unable to follow current BASHH 
non-gonococcal urethritis guidelines [6], a review of the 
current evidence on the complications of NCNGU in 
men is urgently warranted.
Non-gonococcal urethritis has traditionally been dis-
tinguished from gonococcal urethritis on the bases of the 
absence of Gram-negative diplococci on Gram-stained 
microscopy. Progress in microbiological diagnosis now 
enables more specific testing for the causative pathogens 
in urethritis and nucleic acid amplification tests (NAATs) 
for gonorrhea and chlamydia are now favored in diagno-
sis. This in part has enabled NCNGU, sometimes called 
non-specific urethritis, to emerge as a diagnostic cate-
gory. Causes of NCNGU include Mycoplasma genital-
ium, Ureaplasma urealyticum, Trichomonas vaginalis, 
adenovirus, herpes simplex virus (HSV) and in rare cases 
Mycoplasma hominis and Ureaplasma parvum, as well 
as non-infectious causes [9–11]. The aim of this system-
atic review is to summarize and evaluate the available 
evidence regarding whether NCNGU causes the signifi-
cant complications that are already well-recognized to 
be associated with non-gonococcal urethritis. These sig-
nificant complications are epididymo-orchitis, balanopo-
sthitis, and sexually-acquired reactive arthritis (Reiter’s 
syndrome) including arthritis or conjunctivitis.
Materials and Methods
The Preferred Reporting Items for Systematic Reviews and 
Meta-Analyses review protocol was used and the review was pro-
spectively registered on PROSPERO.
Study Characteristics and Eligibility Criteria
The review included studies published after January 1993, be-
cause this was the year in which NAAT for Chlamydia trachoma-
tis became commercially available [12], up to and including Au-
gust 2018. For practical reasons the review included only studies 
published in English.
Participants Men identified to have either symptomatic or 
asymptomatic NCNGU.
Inclusion Criteria Study participants had to meet the following 
inclusion criteria, based on current UK best practice guidelines 
[1, 13, 14]: (1) Men with, upon methylene-blue or Gram-staining, 
either a) an anterior urethral smear demonstrating ≥ 5 polymor-
phonuclear neutrophil leukocytes (PMNLs) per high power (× 
1,000) microscopic field (averaged over 5 fields with the greatest 
concentration of PMNLs) or b) a spun first-pass urine or strands 
visually identified in a first-pass urine demonstrating ≥ 10 PMNLs 
per high power (× 1,000) microscopic field (averaged over 5 fields 
with the greatest concentration of PMNLs). If explicitly stated, 
studies with a higher threshold for microscopic diagnosis were in-
cluded. (2) A negative first-pass urine or urethral swab NAAT test 
for Chlamydia trachomatis. (3) A negative NAAT, microscopy or 
culture test for gonorrhea (provided that neither of the other 2 tests 
for gonorrhea was positive).
Exclusion Criteria Studies which did not undertake micros-
copy for diagnosis (for example studies which used a leukocyte 
esterase test to diagnose urethritis) and studies which relied on 
alternative techniques such as enzyme immunoassay for diagnosis 
of chlamydia or gonorrhoea, because of unreliable sensitivity [1, 
15]. Review articles and meta-analyses were also excluded.
Study Design Studies reporting clinical outcomes for men with 
NCNGU, including trials, observational studies and case reports 
were included. No limit was placed on the length of follow-up 
within the studies, in order to minimize the chance of excluding 
potentially relevant studies identifying a long latency from infec-
tion to complications [4].
Validity The number of studies relating to the complications of 
NCNGU is low and therefore studies were included regardless of 
their validity as assessed by the researcher.
Information Sources
Five databases were searched (PubMed, EMBASE, Cumula-
tive Index to Nursing and Allied Health Literature, PsycINFO, 
and British Nursing Index). These were chosen based on their ac-
cepted breadth and scope [16]. The search terms used were: “non
-chlamydial”; “non-gonococcal”; “urethritis”; “NCNGU”; “epi-
didymitis”; “orchitis”; “epididymo-orchitis”; “sexually-acquired 
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reactive arthritis”; “Reiter’s syndrome”; “balanoposthitis”. The 
dates of coverage of these databases were 1993 to 2018, and the 
date last searched was 23/09/2018. An example of the electronic 
search method is found in figure 1.
Study Selection Process
Titles and abstracts were compared for similarity using text 
comparison software [17] and duplicates excluded. The remaining 
records were screened by the researcher and assessed for potential 
relevance. A second researcher then independently assessed the 
records for potential relevance in order to minimize selection bias. 
The concordance between the 2 researchers was 86%. If potential 
relevance was unclear from the abstract, a full text was obtained 
and assessed. The abstracts were then categorized as either ‘for 
exclusion’ or ‘for further assessment to determine eligibility’ or 
‘editorial or review article’. Full text articles were obtained for 
studies categorized as ‘for further assessment to determine eligi-
bility’. Based upon the eligibility criteria, these articles were then 
allocated to either ‘for exclusion’ or ‘for inclusion’. To reduce 
bias, this process was undertaken by both researchers indepen-
dently and any disagreements were resolved by discussion.
Finally, in order to capture articles potentially meeting the in-
clusion criteria but with titles and abstracts missed by the litera-
ture search, full texts were obtained for all articles categorized as 
either ‘for inclusion’ or ‘editorial or review article’. Their refer-
ences were then screened by both researchers, and full texts were 
retrieved for any references identified as potentially meeting the 
inclusion criteria. These texts were then categorized as either ‘for 
inclusion’ or ‘for exclusion’. This categorization was conducted 
by both researchers independently and again any disagreements 
were resolved by discussion. Data were extracted by the primary 
researcher and entered into a pre-written data abstraction pro-
forma.
Data Items Collected and Assumptions Made
The data items collected were study setting and design; sample 
size; diagnostic criterion used for NCNGU; whether participants 
were symptomatic or asymptomatic; significant well-recognized 
clinical complications of non-gonococcal urethritis reported (spe-
cifically epididymo-orchitis, sexually-acquired reactive arthritis 
(Reiter’s syndrome) including arthritis or conjunctivitis, or bal-
anoposthitis) and whether the sample was also identified as pos-
itive for Mycoplasma genitalium through NAAT testing. It was 
assumed that complications were diagnosed accurately according 
to accepted best medical practice.
Assessing for Bias
The quality of studies was assessed for the risk of bias. Obser-
vational studies, including cohort and case-control studies, were 
evaluated using the Newcastle-Ottawa Scale [18]. This scale uses 
a star system to assess participant selection, comparability of study 
groups, and ascertainment of outcomes. The following thresholds 
were used for scoring studies: (1) Good quality: 3 or 4 stars in se-
lection domain AND 1 or 2 stars in comparability domain AND 2 
or 3 stars in outcome/exposure domain; (2) Fair quality: 2 stars in 
selection domain AND 1 or 2 stars in comparability domain AND 
2 or 3 stars in outcome/exposure domain; (3) Poor quality: 0 or 1 
star in selection domain OR 0 star in comparability domain OR 0 
or 1 star in outcome/exposure domain.
For case reports and case series, a modified version of the New-
castle-Ottowa Scale was applied. This modified scale removes 
items relating to comparability and adjustment and focuses on 
selection, representativeness of cases, exposure and ascertainment 
of outcomes. This modified scale has been successfully applied in 
several published systematic reviews [19]. For this modified scale 
the following thresholds were used: (1) Good quality: 1 star in 
selection domain, 2 stars in ascertainment domain, 3 or 4 stars in 
((ncngu).ti,ab OR ((non-chlamydial).ti,ab AND (urethritis).ti,ab) OR
((non-gonococcal).ti,ab AND (urethritis).ti,ab) OR ((urethritis).ti,ab
AND (reiter’s syndrome).ti,ab) OR ((urethritis).ti,ab AND
(sexually-acquired reactive arthritis).ti,ab) OR ((urethritis).ti,ab
AND (balanoposthitis).ti,ab) OR ((urethritis).ti,ab AND
(epididymitis).ti,ab) OR ((urethritis).ti,ab AND (orchitis).ti,ab) OR
((urethritis).ti,ab AND (epididymo-orchitis).ti,ab) OR ((nonchlamydial).
ti,ab AND (reiter’s syndrome).ti,ab) OR ((nonchlamydial).
ti,ab AND (sexually-acquired reactive arthritis).ti,ab)
OR ((non-chlamydial).ti,ab AND (balanoposthitis).ti,ab) OR ((nonchlamydial).
ti,ab AND (epididymitis).ti,ab) OR ((nonchlamydial).
ti,ab AND (orchitis).ti,ab) OR ((non-chlamydial).ti,ab
AND (epididymo-orchitis).ti,ab) OR ((non-gonococcal).ti,ab AND
(reiter’s syndrome).ti,ab) OR ((non-gonococcal).ti,ab AND
(sexually-acquired reactive arthritis).ti,ab) OR ((nongonococcal).
ti,ab AND (balanoposthitis).ti,ab) OR ((nongonococcal).
ti,ab AND (epididymitis).ti,ab) OR ((nongonococcal).
ti,ab AND (orchitis).ti,ab) OR ((non-gonococcal).ti,ab
AND (epididymo-orchitis).ti,ab)) [DT FROM 1993]
Fig. 1. Example of electronic search method.
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causality domain and 1 star in reporting domain; (2) Fair quality: 
1 star in the selection domain, 1 star in the ascertainment domain, 
2 stars in the causality domain and 1 star in the reporting domain; 
(3) Poor quality: no stars in either the selection, ascertainment or 
reporting domain, or no or 1 star in the causality domain.
For cross-sectional studies an adapted Newcastle-Ottawa scale 
[20], used successfully in Herzog et al. [21] was used. The fol-
lowing thresholds were used: (1) Good quality: 4 or 5 stars in 
selection domain, 2 stars in ascertainment domain, 3 or 4 stars in 
outcome domain; (2) Fair quality: 3 stars in the selection domain, 
1 star in the ascertainment domain, 2 stars in the outcome domain; 
(3) Poor quality: no, 1 or 2 stars in the selection, no stars in ascer-
tainment domain, or no or 1 star in the outcome domain.
This information was then considered and its relevance ex-
plored in the discussion and conclusion of the systematic review. 
Additionally, risk of bias across studies (for example reporting 
and publication bias) was considered.
Results
Total 2,196 records were identified in the initial 
search, of which 1,058 were identified as duplicates and 
excluded. The titles and abstracts of the remaining 1,138 
Results identified through 
database searching (n = 2,196)
Records after duplicates 
removed (n = 1,138)
Records excluded (n = 1,009)
Full text articles assessed 
for eligibility (n = 129)
Full text articles excluded 
(n = 90)
Review/editorial 
articles identified (n = 34)
Articles included in 
qualitiative synthesis (n = 5)
93 articles identified as 
potentially relevant 
from references
Full text articles 
excluded (n = 91)
Articles included in 
qualitiative synthesis (n = 2)
Articles included in 
qualitiative synthesis (n = 7)
Fig. 2. Flowchart showing the study selection process.
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unique records were screened for potential relevance. And 
129 were identified as potentially relevant original arti-
cles, and their full texts were evaluated against the inclu-
sion and exclusion criteria. From this pool, 5 articles met 
the inclusion criteria and were included in the synthesis.
Total 34 potentially relevant studies were identified 
as review or editorial articles, and their references were 
screened for potential relevance. Full text articles were 
sought for 93 articles, and these articles were evaluated 
against the inclusion and exclusion criteria. Two articles 
from this pool met the inclusion criteria and were added 
to the synthesis, leaving a total of 7 articles included in 
the synthesis. A flowchart showed the study selection 
process (fig. 2). Data extraction process was summarized 
in table 1 [22–28].
The 7 included studies consisted of 2 retrospective co-
hort studies, 1 case series, 2 case reports and 2 cross-sec-
tional studies. No prospective studies met the inclusion 
criteria, and no published systematic reviews were found 
on the topic.
The critical appraisal of each of the studies individu-
ally, utilizing variations of the Newcastle-Ottawa scale 
as described in the methods section, is presented in ta-
ble 2. Risk of bias across studies also requires consid-
eration: case reports and case series are included within 
this systematic review, and this introduces a risk of re-
porting bias because case reports highlighting the ab-
sence of complications are seldom published except in 
specific circumstances. In this review, no case reports or 
case series were identified that highlighted the absence 
of any complication. However, because the primary aim 
of this review is to ascertain whether NCNGU does cause 
significant complications, and not the incidence of these 
complications, this justifies inclusion of case reports and 
case series.
The included studies described and analysed 3 types 
of complication: balanitis, posthitis and/or meatitis; reac-
tive arthritis and/or conjunctivitis; and epididymitis.
Balanitis, Posthitis and/or Meatitis
There are 4 studies analyzed balanitis, posthitis and/
or meatitis. This included 2 good quality retrospective 
cohort studies, 1 fair quality case series study and 1 good 
quality cross-sectional study. One study was performed 
in the UK, 1 in Australia and 2 in Japan.
Table 1. Pre-written data extraction
Number
1
2
3
4
5
6
7
HPF = High power field.
Lead author 
and date
Location Study 
design
Year(s) of 
study
Sample size 
(men with 
NCNGU)
Diagnostic criterion 
used for NCNGU
Symptomatic Complication(s) 
reported
Mycoplasma gen-
italium positively 
identified
Ito et al. 
(2016)
Chrisment 
et al. (2013)
Horner et 
al. (2011)
Falk et al. 
(2004)
Ito et al. 
(2017)
Ong et al. 
(2017)
Björnelius 
et al. (2004)
cross-sectional
case report
retrospective 
cohort
cross-sectional
case series
retrospective 
cohort
case report
April 2013– 
July 2015
March 2011
1991–1993
February 2000 
–July 2000
April 2013 
–December 
2015
2000–2015
not provided
109
    1
  
  56
207
  
  10
  80
   
    1
≥ 5 leukocytes per 
HPF (× 1,000) in 
their Gram-stained 
urethral smear 
≥ 5 leukocytes 
per HPF (× 1,000) 
per Gram-stained 
urethral smear 
≥ 5 PMNLs per 
HPF (× 1,000) in 
5 or more fields 
of a Gram-stained 
urethral smear
≥ 5 PMNLs per 
HPF (× 1,000)
≥ 5 PMNLs per 
HPF (× 1,000)
≥ 5 PMNLs per 
HPF (× 1,000)
> 30 PMNs per 
HPF (× 1,000)
yes
yes
yes
yes
yes
yes
yes
balanitis: 51 
cases;
conjunctivitis: 6  
cases
reactive arthritis: 
1 case
balanoposthitis: 
12 cases
epididymitis: 
1 case
balanoposthitis 
(meatitis): 6 
cases
balanoposthitis 
(meatitis): 50 
cases
conjunctivitis: 
1 case
22 cases, of which 
9 had balanitis 
and none reported 
conjunctivitis
yes
yes: Mycoplasma 
genitalium found 
to be significantly 
associated with 
balanoposthitis but 
original figures not 
available
yes: 27 cases (none 
with epididymitis)
yes: 1 of the 6 
cases of meatitis 
was mixed HSV 
and Mycoplasma 
genitalium
no
yes (PCR positive 
for both first void 
urine sample and 
conjunctival swab)
Gifu, Japan
Bordeaux, 
France
London, UK
Örebro, 
Sweden
Sendai, 
Japan
Melbourne, 
Australia
Stockholm, 
Sweden
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Table 2. Assessment of risk of bias [19]
Domain Criterion Score Study 3 (Horner et. 
al. 2011)
Study 6 (Ong et. al. 
2017)
Selection
Comparability
Outcome
representativeness of the exposed cohort
selection of the non-exposed cohort
ascertainment of exposure
demonstration that the outcome of interest was 
not present at the part of the study
comparability of cohorts on the basis of the 
design or analysis
assessment of outcome
was follow-up long enough for outcomes (the 
pre-specified complications of male urethritis) 
to occur
adequacy of follow up of cohorts
• truly representative of the average man with 
NCNGU in the community*
• somewhat representative of the average man 
with NCNGU in the community*
• selected group of users
• no description
• drawn from the same community as the 
exposed cohort*
• drawn from a different source
• no description
• secure method*
• structured interview*
• written self report
• no description
• yes*
• no
• study controls for comorbid genito-urinary 
infection*
• study controls for any additional factor*
• independent blind assessment*
• record linkage*
• self-report
• no description
• yes*
• no
• complete follow-up – all subjects accounted 
for *
• subjects lost unlikely to introduce bias 
(<10% loss or description of those lost)
• follow-up rate >10% and no description of 
those lost
• no statement
*
*
*
–
**
*
*
–
*
*
*
–
**
*
–
*
Cohort
Case reports and case-series
Domain Score Study 5 (Ito et. al. 
2017)
Study 7 (Björnelius 
et. al. 2004)
Selection
Ascertainment
Causality
Reporting
• does the patient(s) represent(s) the whole 
experience of the investigator (centre) or is 
the selection method unclear to the extent that 
other patients with similar presentation may not 
have been reported?*
• was the exposure adequately ascertained?*
• was the outcome adequately ascertained?*
• were other alternative causes that may explain 
the observation  ruled out?*
• was there a challenge/ re-challenge phenom-
enon?*
• was there a dose-response effect?*
• was follow-up long enough for outcomes to 
occur?*
• is the case(s) described with sufficient details 
to allow other investigators to replicate the 
research or to allow practitioners make infer-
ences related to their own practice?*
–
**
**
*
*
**
**
*
*
**
*
*
Study 2 (Chrisment 
et. al. 2013)
Cross sectional
Domain Criterion Score Study 1 (Ito et. al. 
(2016)
Study 4 (Falk et. 
al. 2004)
Selection representativeness of the sample • truly representative of the average man with 
NCNGU in the community (all subjects or 
random sampling)*
• somewhat representative of the average man 
with NCNGU in the community (non-random 
sampling)*
• selected group of users
• no description
* *
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Comparability
Outcome
sample size
non-respondents
ascertainment of the exposure (NCNGU)
are subjects in different outcome groups are 
comparable, based on the study design or anal-
ysis, and are confounding factors controlled
assessment of outcome
statistical test
• justified and satisfactory*
• not justified
• comparability between respondents and non
-respondents is established, and the response 
rate is satisfactory*
• the response rate is unsatisfactory, or compa-
rability between respondents and non-respon-
dents is unsatisfactory
• no description of the response rate or the 
characteristics of the responders and the 
non-responders
• validated measurement tool**
• non-validated measurement tool, but the tool 
is available or described*
• no description of the measurement tool
• the study controls for comorbid genitouri-
nary infection*
• study controls for any additional factor*
• independent blind assessment**
• record linkage**
• self-report*
• no description
• the statistical test used to analyse the data 
is clearly described and appropriate, and the 
measurement of the association is presented, 
including confidence intervals and p value*
• the statistical test is not appropriate, not 
described or incomplete
–
*
**
**
**
*
–
*
**
**
**
–
Domain Criterion Score Study 4 (Butrimiene 
et. al. 2009)a
Selection
Comparability
Exposure
is the case definition adequate?
representativeness of cases
selection of controls
definition of controls
comparability of cases and controls on the basis 
of the design or analysis
ascertainment of exposure
same method of ascertainment for cases and 
controls
non-response rate
• yes, with independent validation*
• yes, eg. with linkage of records or based on self reports
• no description
• consecutive or obviously representative series of cases*
• potential for selection biases or not stated
• community controls*
• hospital controls
• no description
• no history of the complication(s)*
• no description of source
• study controls for comorbid genito-urinary infection*
• study controls for any additional factor*
• secure method*
• structured interview where blind to case/ control status*
• non-blinded interview
• written self-report or medical record only
• no description
• yes*
• no
• same rate for both groups*
• non-respondents described
• rate different and no designation
–
*
–
*
*
**
*
–
Case-control
aDid not meet criteria for inclusion in final analysis; *Refers to the number of points received in that category by the paper. The number of stars is the 
score (1 to 2, shown as *, **) for that criterion on the modified Ottowa-Newcastle bias scale.
Ito et al. [22] presented a fair quality cross-sectional 
study of men presenting to a urology clinic with urethri-
tis symptoms. Urethral swabs were analyzed for Chlamy-
dia trachomatis, Neisseria gonorrhoea, human adenovi-
rus, Haemophilus influenzae, HSV 1 and 2, Mycoplasma 
genitalium and Ureaplasma urealyticum. Data on com-
plications was presented only where men were identified 
to have monomicrobial NCNGU, or where no causative 
organism was found. Total 109 cases of NCNGU were 
identified, and 51/109 had evidence of balanitis on geni-
tal examination at the time of presentation. The rates bro-
ken down by causative organism were Mycoplasma geni-
talium 9/22, Ureaplasma urealyticum 6/14, Haemophilus 
influenzae 3/21, human adenovirus 11/12, HSV 7/11, no 
organism identified 15/29.
The 2 good quality retrospective cohort studies both 
compared the clinical course of NCNGU with chlamy-
dial NGU. However, they cannot be compared because 
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while Horner et al. [24] excluded participants with HSV 
PCR-positive NCNGU, Ong et al. [27] included only 
men with HSV PCR-positive NCNGU.
Horner et al. [24] studied 114 men with NGU, of which 
they identified 56 men as having NCNGU and 12/56 
(21%) were diagnosed with “balanitis and/or posthitis” 
(defined as erythema of the glans and/or prepuce on geni-
tal examination at the time of presentation). The men un-
derwent further testing for Ureaplasma urealyticum and 
Mycoplasma genitalium. The report does not provide a 
breakdown of data on which men with mycoplasma or 
ureaplasma were negative for chlamydia. Therefore, it is 
not possible to make conclusions about the capacity for 
either Ureaplasma urealyticum or Mycoplasma genital-
ium alone to cause balanitis and/or posthitis. However, the 
study does report that while the presence of Ureaplasma 
urealyticum (in men with and without chlamydia) did 
not increase the risk of balanitis and/or posthitis (odds 
ratio = 1; CI 0.28–3.23), the presence of Mycoplasma 
genitalium did (odds ratio = 4.12; CI 1.29–13.38). Fur-
thermore, when the authors controlled for the presence of 
discharge, which could itself potentially cause or contrib-
ute to balantitis/posthitis, they found that Mycoplasma 
genitalium presence continued to be associated with 
balanitis and/or posthitis (odds ratio = 4.1, CI 1.2–13.5). 
Total 86/114 were followed-up between 10 and 90 days 
after initial presentation, after receiving either 13 days of 
doxycycline or 14 days of erythromycin. At follow-up 
examination, 2 men who had originally been positive for 
Mycoplasma genitalium had balanitis and/or posthitis. 
One of these men had not had balanitis and/or posthitis 
originally. Both were Mycoplasma genitalium-negative 
at follow-up. However, no data is available on whether 
these men were also positive for Chlamydia trachomatis 
therefore they cannot be described as cases of NCNGU.
Ong et al. [27] included 80 men with HSV (25 HSV-
1 and 55 HSV-2). Men co-infected with Mycoplasma 
genitalium were excluded. The study found that men 
with HSV were more likely to have meatitis than those 
with Chlamydia trachomatis [50/80 (62%, CI 52–72) vs. 
17/80 (23%, CI 14–32), p < 0.01].
Ito et al. [26] presented a fair quality case series report-
ing 10 cases of HSV PCR-positive NCNGU. It was un-
known whether these cases of HSV urethritis represented 
first-episode or recurrent (reactivation) HSV infection. 
Of these 10 men, 6 had meatitis on genital examination. 
Eight of the 10 men were followed-up 7–19 days later, 
after receiving empirical treatment for urethritis (either 7 
days of 100 mg sitafloxacin twice daily or with a single-
dose regimen of 2 g extended-released azithromycin). At 
this follow-up visit, men were re-tested for HSV and un-
derwent repeat genial examinations. Two men were still 
positive for HSV. On genital examination, 1 of the 8 men 
had ongoing meatitis, despite a negative test for HSV.
Reactive Arthritis and/or Conjunctivitis
Three studies analyzed reactive arthritis and/or con-
junctivitis. This included 1 fair quality cross-sectional 
study and 2 poor quality case reports. One study was per-
formed in Japan, 1 in France and 1 in Sweden.
Ito et al. [22] described in the previous section, as-
sessed men with NCNGU for self-reported conjunctivitis 
symptoms (“pink or red color in the whites of the eyes; 
increased tearing; discharge of pus”). The presence of 
self-reported symptoms of conjunctivitis was assessed 
in the 109 included men with monomicrobial NCNGU. 
Conjunctivitis was identified only in men with viral 
urethritis (human adenovirus 1/11; HSV 5/12). None 
of the men positive for solely Mycoplasma genitalium, 
Ureaplasma urealyticum or Haemophilus influenzae, or 
those with no organism identified, reported conjunctivi-
tis.
Both case reports described cases of inflammatory 
reactions (reactive arthritis and conjunctivitis) in young 
men and attributed them to Mycoplasma genitalium. 
Chrisment et al. [23] reported a case of reactive arthri-
tis complicating Mycoplasma genitalium urethritis in an 
HLA-B27-positive 29-year-old man. During the disease 
course the patient’s clinical presentation included gen-
ital lesions, urethritis, inguinal lymphadenopathy, peri-
anal intertrigo, oral aphthous ulcers, and oligoarthritis, 
but no conjunctivitis. Biochemical tests revealed a raised 
C-reactive protein, raised white blood cell count and 
HLA-B27 positivity, but the patient tested negative for 
a range of rheumatological and viral causes of this pre-
sentation and negative for chlamydia and gonorrhea. An-
timycosis treatment, NSAIDS, amoxicillin/clavulanate, 
and doxycycline and ceftriaxone failed to improve the 
patient’s clinical condition. Following this, Mycoplasma 
genitalium was detected with PCR in 2 urine samples. 
The patient was then treated with 400 mg of moxifloxa-
cin daily for 10 days, with the aim of treating the Mycop-
lasma genitalium. Four days after completing this course 
he failed to improve and methotrexate therapy was initi-
ated. This was continued for 7 weeks at which point the 
patient’s clinical condition had improved significantly. 
Although Mycoplasma genitalium was not obtained from 
synovial fluid aspirated, at the time of the aspiration the 
patient has already received 6 days of moxifloxacin, 
which may have impacted this detection.
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Björnelius et al. [28] reported the case of a 22-year-
old white, otherwise healthy man with a 5-month history 
of unilateral eye irritation and a several month history of 
urethritis symptoms. He had failed treatment for allergic 
conjunctivitis but had received no antibiotics during this 
period. A conjunctival swab and urine specimens were 
positive for Mycoplasma genitalium DNA on PCR, but 
negative for Chlamydia trachomatis and Neisseria gon-
orrhoea. He received doxycycline for 10 days. Six weeks 
after initiation of treatment clinical signs and symptoms 
diminished and conjunctival samples tested negative for 
Mycoplasma genitalium. Nine weeks after initiation of 
treatment clinical signs and symptoms had resolved com-
pletely and a first void urine sample also tested negative 
for Mycoplasma genitalium. The sequence of the strain 
of Mycoplasma genitalium found in the urine samples 
was found to be identical to the sequence obtained from 
the conjunctival specimen, strengthening the hypothesis 
that Mycoplasma genitalium was the causative agent in 
the conjunctivitis.
Epididymitis
One good quality cross-sectional study to analyze 
epididymitis was performed in Sweden [25]. This study 
compared the prevalence and clinical features of Myco-
plasma genitalium and Chlamydia trachomatis infec-
tions in men attending an STD clinic. Men were tested 
for Mycoplasma genitalium, Neisseria gonorrhoea and 
Chlamydia trachomatis. The only complication assessed 
for was symptoms of epididymitis. Total 207 men were 
identified as having either only Mycoplasma genitalium 
or all negative tests and 1 man was identified as having 
symptoms of epididymitis. In this patient Mycoplasma 
genitalium was detected with PCR using primers detect-
ing the Mycoplasma genitalium 16S rRNA gene, how-
ever confirmation of this result with a PCR detecting the 
MgPa adhesin gene (the same locus as that used to diag-
nose Mycoplasma genitalium in Chrisment et al. [23]) in 
accordance with the study’s protocol failed, and thus the 
man was classed as having all negative tests.
Discussion
This review identifies and summarizes the available 
evidence on whether NCNGU is associated with signifi-
cant clinical complications in men. The breadth in in-
clusion criteria enabled studies with a diverse range of 
methodologies and variables to be incorporated in this 
analysis. As such, there was substantial heterogeneity in 
the eligibility criteria specified within the studies, espe-
cially with respect to which etiologies of urethritis were 
included or excluded. This is most clearly demonstrated 
by the decision by Horner et al. [24] to include men pos-
itive for Mycoplasma genitalium but exclude men posi-
tive for HSV, in contrast to the decision by Ong et al. [27] 
to include only men positive for HSV and exclude men 
positive for Mycoplasma genitalium. As is discussed in 
the conclusion, this diversity in the eligibility criteria is a 
significant limitation to the external validity of the avail-
able evidence on this topic. A further general limitation 
to the ability to draw clear conclusions is that no pro-
spective studies met the inclusion criteria for this review. 
Well-designed prospective studies can provide evidence 
of temporality, dose-response, specificity and statistical 
strength of association, all of which can provide evidence 
of a causal relationship between variables [29]. Further-
more, prospective cohort studies are regarded as the 
strongest evidence for assessing symptom prevalence, 
including complications [30].
The results of the included studies do consistently in-
dicate that an association between urethritis and balanitis, 
posthitis and/or meatitis exists. Unfortunately, conclu-
sions cannot be drawn about whether this relationship is 
causal. This owes largely to the fact that both retrospective 
cohort studies as well as the cross-sectional study mea-
sured the presence of balanitis, posthitis and/or meatitis 
at the time of presentation. Therefore, no conclusions 
about the temporal relationship between urethritis and 
the complications can be drawn. Additionally, no studies 
looked at dose-response relationships between the caus-
ative organisms and the development of complications.
Only one study [27] could show a causative relation-
ship between NCNGU (specifically HSV) and meatitis 
on the grounds of men having a higher relative risk of me-
atitis when compared to men with chlamydia. However, 
although this study is classed as good quality according 
to the Newcastle-Ottawa scale, there is a significant lim-
itation to the validity of the study’s meatitis results spe-
cifically. Testing for HSV was performed when the cli-
nician suspected a viral cause of urethritis, rather than in 
all men. The clinic’s guidelines recommend suspecting 
and testing for a viral cause of urethritis (such as HSV 
or adenovirus) where there is “meatitis and severe dys-
uria with or without conjunctivitis”. Therefore, men with 
HSV but no meatitis may have forgone an HSV test. This 
has the potential to significantly bias the results of the 
study relating to meatitis.
Ito et al. [22] present an association between viral ure-
thritis (specifically adenovirus and HSV) and conjunc-
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tivitis. Both adenovirus and HSV are well-established 
causes of viral conjunctivitis, with adenovirus being the 
most common cause of viral conjunctivitis [31]. Chlamy-
dia trachomatis is known to cause conjunctivitis through 
autoinoculation via the hands, which adds biological 
plausibility to the claim that the same could be true of 
other causes of urethritis [32]. However, there is an im-
portant distinction between viral infectious conjunctivi-
tis, such as that known to be caused by HSV and aden-
ovirus, and conjunctivitis seen as part of the spectrum 
of reactive arthritis. While the latter can be seen as an 
established clinical complication of urethritis, the former 
is best seen as a coexisting infective condition [9, 31]. Ito 
et al. [22] did not test conjunctival swabs for adenovirus 
or HSV, and in conducting a cross-sectional study they 
were unable to assess for the temporal relationship be-
tween the urethritis and conjunctivitis, so it is difficult to 
conclude that the conjunctivitis was infective rather than 
reactive. Therefore, while this paper provides compelling 
evidence that viral urethritis is associated with conjuncti-
vitis it adds little evidence to the theory that viral urethri-
tis causes the clinical complication of reactive arthritis. It 
is also interesting that none of the 86 cases of non-viral 
NCNGU were found to be associated with conjunctivitis 
in this study.
The 2 case reports discussing reactive arthritis and/or 
conjunctivitis provide interesting and important insights. 
These studies derive significant value on the grounds of 
the biological plausibility of the associations described 
and by analogies to other known causes of reactive ar-
thritis and conjunctivitis, such as Chlamydia trachoma-
tis. However, there are important considerations regard-
ing the specificity of the results that limit conclusions 
drawn about a causative link between NCNGU and re-
active arthritis and/or conjunctivitis. Major limitations to 
Björnelius et al. [28] are that potential alternative causes 
that may explain the conjunctivitis were not adequately 
ruled out. As Ito et al. [22] find, adenovirus and HSV 
are potential causes of conjunctivitis and urethritis and 
neither were tested for in this case report.
In support of their diagnosis of a case of reactive ar-
thritis caused by Mycoplasma genitalium, Chrisment et 
al. [23] 2013 adequately exclude an array of competing 
diagnoses. It remains difficult to rule out a competing 
diagnosis to Mycoplasma genitalium-induced reactive 
arthritis, such as an enteric pathogen, or a seronegative 
idiopathic arthritis, particularly because although the 
patient’s clinical condition began to improve within the 
month after Mycoplasma genitalium was appropriately 
treated (though eradication of Mycoplasma genitalium 
from the urethra was not confirmed following treatment). 
This coincided with introduction of methotrexate, bring-
ing into question any causal link between Mycoplasma 
genitalium eradication and resolution of the reactive ar-
thritis. However, this does not necessarily invalidate the 
conclusion of a causal link because typically infections 
are regarded as triggering rather than sustaining agents 
in reactive arthritis [33]. It is also important to note that 
Chrisment et al. [23] report a case where the patient was 
HLA-B27 positive, which potentially limits the rele-
vance of this report to the wider population of men with 
NCNGU.
A fair quality case-control study aiming to identify 
potential triggering infections for sexually-acquired re-
active arthritis in both men and women compared uro-
genital tract inflammation and infection in 120 reactive 
arthritis patients with 2 control groups. The first control 
group consisted of 85 patients with other arthritides, and 
the second control group was 52 healthy persons. Differ-
ential data for men and women were not provided. All 
reactive arthritis patients experienced urogenital symp-
toms within a month before developing arthritis. The 
study, conducted in Vilnius, Lithuania, identified 3 cases 
of reactive arthritis in patients with Mycoplasma geni-
talium infection. No data was provided on whether these 
patients were co-infected with Chlamydia trachomatis (a 
known cause of reactive arthritis). A critical appraisal of 
this paper using the Newcastle-Ottawa Scale is provided 
in table 2. A further case series exists which does iden-
tify Mycoplasma genitalium in the joints of patients with 
arthritis, but it failed to meet this review’s inclusion crite-
ria for urethritis [34].The data suggesting a possible link 
between NCNGU and reactive arthritis is so far limited 
and this observation suggests that further research in this 
area would be highly worthwhile. In his review of current 
knowledge on Mycoplasma genitalium, Taylor-Robinson 
[5] argues that an etiological role of Mycoplasma gen-
italium in epididymo-orchitis seems likely by analogy 
with Chlamydia trachomatis. He recommends examin-
ing epididymal aspirates for the microbe as the optimal 
way to investigate such a role.
Very limited evidence was found addressing the ques-
tion of whether NCNGU causes epididymo-orchitis. 
Only one cross-sectional study [25] was found reacting 
to this topic, and while it was good quality the presence 
of epididymitis was not a primary outcome measure. The 
study design limits any conclusions about causation, and 
also introduces the possibility that cases of complications 
could have been missed: though patients were asked to 
re-attend for a follow-up visit 4–5 weeks after commenc-
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ing antibiotic treatment, no information is given as to 
whether any complications were assessed for at the fol-
low-up appointment, including epididymitis. Thus, a sig-
nificant limitation of this study is that no conclusions can 
be drawn about the development of complications with 
time. This study does, however, suggest at least a possi-
ble relationship between NCNGU and epididymo-orchi-
tis and the absence of other relevant studies indicates a 
significant gap in the literature on this topic.
A number of studies that failed to meet the inclusion 
criteria for this review analyze the potential etiological 
agents for urethritis to cause epididymitis. Ito et al. [22] 
in their study of 56 young men with acute epididymitis, 
identified 25 men with co-existing NCNGU who were 
also negative for Gram-negative bacilli (which would in-
dicate a urinary tract infection rather than urethritis as 
the cause of the epididymitis). In these 25 men, Myco-
plasma genitalium or Ureaplasma urealyticum was de-
tected in 1 man each (4.0%), and Mycoplasma hominis 
and/or Ureaplasma parvum was detected in 5 (20.0%). 
This study, while both interesting and relevant for the 
evidence it provides towards NCNGU being a potential 
cause of epididymitis, could not be included in this re-
view because it failed to adequately exclude gonorrhea 
as a cause of the symptoms (the diagnostic tool used was 
culture only rather than NAAT) and because first void 
urine samples rather than urethral smears were used to 
identify cases of urethritis. Similarly, Hoosen et al. [35] 
investigated the etiology of acute epididymitis in a com-
munity in Durban, South Africa. Of the 144 men identi-
fied to have acute epididymitis, data were not extractable 
for how many of these men met the criteria for NCNGU. 
However, it is possible to extract that 9 men positive 
Ureaplasma urealyticum met the criteria for NCNGU. 
This is a very interesting finding. However, this paper 
could not be included in the review because microscopy 
and detection of Chlamydia trachomatis antigen by di-
rect immunofluorescence, rather than NAAT testing, 
was used as the diagnostic criterion for chlamydia, and 
the threshold used was 4 rather than 5 or more PMNLs 
per high power (×1,000) microscopic field [35]. Finally, 
a randomized controlled trial into competing antibiotic 
treatments for acute epididymitis in men over 40 years 
old also found that  of 172 men diagnosed with acute 
epididymitis 3 tested positive for Mycoplasma hominis, 
3 for Mycoplasma genitalium, and 24 for ureaplasma. 
This study failed to meet the inclusion criteria for diag-
nosis of urethritis, however, and data were not available 
for whether these patients were coinfected with other or-
ganisms including chlamydia, gonorrhea, or urinary tract 
infection-causing pathogens [36]. The latter is a particu-
larly important limitation because it is possible that these 
men did not have urethritis and instead had a urinary tract 
infection, a condition of which ureaplasma is thought to 
be a cause [37].
The findings of this review also offer important in-
sights relating to the utility of the terminology used in 
both research and clinical practice. The diversity in the 
eligibility criteria in terms of causative organism in the 
studies is a significant limitation to the external validity 
of the available evidence on this topic. In order to make 
meaningful assessments of the risk of complications for 
individuals with urethritis, standardized disease entities 
such as NCNGU must be agreed, defined and utilized 
in research and in clinical practice. The global nature of 
this issue, as evidenced by the range in settings of the 
studies included in this review, is both a motivation and 
a challenge to this endeavor. The studies included in 
this review frequently allude to differences in the com-
plications of NCNGU when broken down by causative 
organism, though there is insufficient data to synthesize 
these effects. These observations bring in to question the 
utility of the term NCNGU, a composite disease entity 
with substantial heterogeneity in how it is defined and 
interpreted. This adds evidence to the view that, where 
available, tests for potential causative organisms in ure-
thritis should be employed in research and in the clinic.
Conclusion
This review has found that there is substantial evi-
dence of an association between NCNGU and balanitis, 
posthitis and/or meatitis. The importance of this finding 
extends beyond the significant burden of morbidity for 
the men it affects: inflammation of the foreskin has been 
identified as a cofactor for HIV transmission [24]. It is 
established that sexually transmitted infections can have 
the potential to facilitate the transmission if HIV, and this 
finding is particularly pertinent given that Mycoplasma 
genitalium has recently been associated with HIV infec-
tion [38–40]. As Horner et al. [24] discuss, Mycoplasma 
genitalium is common in at least 2 populations at high 
risk of HIV: in men who have sex with men (6.6%) and in 
men with urethritis in sub-Saharan Africa [39–41].
Prospective, adequately powered research is urgently 
warranted to establish whether there is a causal link be-
tween NCNGU and significant clinical complications in 
men. The findings from this review indicate that in con-
ducting such research it would be beneficial to further 
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stratify NCNGU cases by causative agent. This could 
also include investigating cases of co-infection by these 
organisms of chlamydial or gonococcal urethritis, or 
multi-microbial NCNGU, because (as noted by Ito et al. 
[26]), organisms which cause NCNGU may have the po-
tential to modulate the disease course of urethritis caused 
by other agents. This could include modulating the inci-
dence of complications.
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